Oncology Institute (DFPH) Invested Capital (2019 - 2026)

Oncology Institute (DFPH) has reported Invested Capital for 8 consecutive years, with $62.3 million the latest figure, recorded in Q1 2026.

• Invested Capital for Q1 2026 came in at $62.3 million, down 21.07% year-over-year; the trailing twelve-month figure through Mar 2026 was $62.3 million (down 21.07% YoY), and the FY2025 annual result was $61.7 million, down 36.23% from the prior year.
• Invested Capital was $62.3 million for Q1 2026 at Oncology Institute, up from $61.7 million in the prior quarter.
• Over five years, Invested Capital peaked at $207.0 million in Q3 2022 and troughed at $61.7 million in Q4 2025.
• Average Invested Capital over 5 years is $123.7 million, with a median of $124.0 million recorded in 2022.
• Year-over-year, Invested Capital jumped 335.49% in 2022 and sank 44.58% in 2025.
• Over 5 years, Invested Capital stood at $203.8 million in 2022, then dropped by 29.41% to $143.9 million in 2023, then plunged by 32.76% to $96.7 million in 2024, then slumped by 36.23% to $61.7 million in 2025, then advanced by 1.05% to $62.3 million in 2026.
• Per Business Quant data, the three most recent Invested Capital figures were $62.3 million in Q1 2026, $61.7 million in Q4 2025, and $63.9 million in Q3 2025.